Allergologie select, Volume 7 (2023) - 1st issue (219 - 228)

AIT 2023: Current innovation and future outlook
Magdalena Zemelka-Wiacek1, Marek Jutel1,2
1 Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, and 2 ALL-MED Medical Research Institute, Wroclaw, Poland

   

 

DOI 10.5414/ALX02379E

Abstract

Although used for over 100 years, allergen immunotherapy (AIT) is still an indispensable tool in modern allergy managemen20t due to its potential to cure allergic diseases. Its current rapid development through the application of personalized and precision medicine approaches is strongly supported by advances in mHealth, component-resolved diagnosis (CRD)-based diagnostics, validation of novel biomarkers, advanced data management, and development of novel preparations. This review summarizes the key advances in the field and shows the perspectives for further development of next-generation AIT treatments.

Author Details

Authors

Departments

  • 1 Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, and
  • 2 ALL-MED Medical Research Institute, Wroclaw, Poland

Address

Marek Jutel and Magdalena Zemelka-Wiacek, Department of Clinical Immunology, Wroclaw Medical University, Parkowa 34, 51-616 Wroclaw, Poland
Email: [email protected]

Citation

Magdalena Zemelka-Wiacek and Marek Jutel. AIT 2023: Current innovation and future outlook. Allergologie Select. 2023; 7: 219-228. doi: 10.5414/ALX02379E.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart